Sanofi (SNYNF) Net Income towards Common Stockholders (2016 - 2025)
Historic Net Income towards Common Stockholders for Sanofi (SNYNF) over the last 17 years, with Q4 2025 value amounting to -$3.3 billion.
- Sanofi's Net Income towards Common Stockholders fell 165531.31% to -$3.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $3.3 billion, marking a year-over-year increase of 437241.82%. This contributed to the annual value of $8.8 billion for FY2025, which is 4672.29% up from last year.
- Per Sanofi's latest filing, its Net Income towards Common Stockholders stood at -$3.3 billion for Q4 2025, which was down 165531.31% from $3.3 billion recorded in Q3 2025.
- Sanofi's 5-year Net Income towards Common Stockholders high stood at $12.2 billion for Q4 2022, and its period low was -$3.3 billion during Q4 2025.
- Over the past 5 years, Sanofi's median Net Income towards Common Stockholders value was $2.4 billion (recorded in 2021), while the average stood at $2.2 billion.
- Examining YoY changes over the last 5 years, Sanofi's Net Income towards Common Stockholders showed a top increase of 751383.86% in 2025 and a maximum decrease of 165531.31% in 2025.
- Sanofi's Net Income towards Common Stockholders (Quarter) stood at $289.9 million in 2021, then soared by 4125.54% to $12.2 billion in 2022, then crashed by 103.86% to -$472.3 million in 2023, then soared by 59.73% to -$190.2 million in 2024, then plummeted by 1655.31% to -$3.3 billion in 2025.
- Its Net Income towards Common Stockholders was -$3.3 billion in Q4 2025, compared to $3.3 billion in Q3 2025 and $3.1 billion in Q2 2025.